Blood Clues Point to Kidney Risk in Children With IgA Vasculitis

A rare purple rash spreading across a child’s legs is often the first visible sign of immunoglobulin A vasculitis, the most common form of small-vessel inflammation in childhood. For most families, the disease runs its course with joint pain and abdominal discomfort and then fades. But in a substantial minority of patients, the same immune process that stains the skin quietly attacks the kidneys, sometimes setting the stage for long-term renal disease. A new prospective cohort study from Türkiye, published in BMC Pediatrics, has examined whether simple blood tests drawn at a child’s first hospital visit can flag which patients are most likely to have kidney involvement.

The research team, led by pediatric nephrologists at Fırat University Faculty of Medicine in Elazığ and a colleague at Çorlu Vega Hospital, followed forty children diagnosed with IgA vasculitis for at least six months. The investigators set out to evaluate a panel of laboratory parameters measured at initial admission: the neutrophil-to-lymphocyte ratio, a marker of systemic inflammation calculated from a routine blood count; serum osmolarity, a measure of the concentration of dissolved particles in the blood; homocysteine, an amino acid linked to vascular injury; vitamin B12; and antiphospholipid antibodies, immune proteins associated with abnormal clotting. Their goal was to determine whether any of these values tracked with renal involvement, the complication that matters most for long-term prognosis.

Immunoglobulin A vasculitis, historically known as Henoch-Schönlein purpura, is a multisystemic disease driven by the deposition of IgA-containing immune complexes in the walls of small blood vessels. Those deposits trigger inflammation that manifests as the characteristic palpable purpura, arthritis or arthralgia, gastrointestinal symptoms ranging from cramping to intussusception, and, in the most clinically consequential scenario, nephritis. According to figures cited in the study, nephritis develops in roughly 20 to 55 percent of children diagnosed with the condition. Because the renal disease can be silent in its early stages, clinicians rely on repeated urinalysis to catch blood or protein in the urine, and the search for additional early-warning markers has been a persistent theme in pediatric rheumatology and nephrology.

The cohort in the new study included twenty-three girls and seventeen boys, a female-to-male ratio of 1.35, with a mean age at diagnosis of approximately nine years. Renal involvement was identified in eleven patients, or 27.5 percent of the cohort. Eight of those children already had kidney involvement at the time of their first hospital presentation, while three developed it during the six-month follow-up period. This timing distinction proved critical to how the authors interpreted their results: in most cases, the laboratory measurements taken at admission were concurrent with kidney disease rather than preceding it, meaning the values reflect an association present at the same moment, not necessarily a prediction of what is to come.

Within that framework, three parameters stood out. Children with renal involvement had significantly higher neutrophil-to-lymphocyte ratios, higher serum urea concentrations, and higher serum osmolarity than children whose disease spared the kidneys. Vitamin B12 levels, by contrast, were significantly lower in the renal group. The differences reached statistical significance at a threshold of p less than 0.05. Serum potassium and homocysteine levels did not differ meaningfully between the two groups, and the presence of antiphospholipid antibodies showed no association with renal involvement, despite hypotheses that have linked these immune proteins to vascular complications in other inflammatory conditions.

The neutrophil-to-lymphocyte ratio deserves particular attention because it is one of the cheapest and most widely available markers in medicine. Neutrophils are the front-line cells of the innate immune system, summoned rapidly to sites of inflammation, while lymphocytes orchestrate adaptive immune responses and are often relatively depleted during acute inflammatory stress. When neutrophils rise or lymphocytes fall, the ratio climbs, offering a crude but reproducible index of systemic inflammatory burden. Elevated ratios have been reported across a wide range of inflammatory, infectious, and autoimmune diseases, and in IgA vasculitis they plausibly mirror the intensity of the immune activation that also drives IgA complex deposition in the glomeruli, the kidney’s microscopic filtering units. The new findings are consistent with that picture, showing that children whose blood already bore the signature of stronger inflammation were also the ones whose kidneys were affected.

The serum osmolarity finding adds a different dimension. Osmolarity reflects the combined concentration of sodium, glucose, urea, and other osmotically active solutes in the blood, and it is typically calculated from a standard chemistry panel rather than measured directly. Elevated osmolarity in children with renal involvement likely relates in part to higher urea concentrations, since urea is a direct contributor to the calculated value and also a marker of declining kidney clearance. In other words, the two elevated markers in the renal group may be partially intertwined, with osmolarity rising because the kidneys were already struggling to excrete nitrogenous waste. That interpretation reinforces the authors’ caution: the laboratory abnormalities may be consequences of early kidney injury as much as they are signals of it.

The lower vitamin B12 levels in the renal group are more enigmatic. Vitamin B12 is essential for red blood cell formation, neurological function, and the metabolism of homocysteine, which was itself not significantly different between the groups in this study. Why children with renal involvement would present with lower B12 is not established by the data, and the authors did not offer a definitive mechanism. Possible connections, such as differences in nutrition, the effects of inflammation on vitamin metabolism, or changes in renal handling of the vitamin, remain speculative. This is precisely the kind of signal that exploratory studies are designed to surface and that larger, more statistically powered investigations must interrogate before any clinical meaning is attached to it.

The authors are unusually direct about the limitations of their conclusions. Because renal involvement was already present in eight of the eleven affected children at the time the blood samples were drawn, the findings should be read as concurrent associations rather than validated predictors. A true predictive marker would need to be measured before kidney disease appears and shown to anticipate it in children who subsequently develop nephritis; only three patients in this cohort fit that temporal pattern, far too few to support a predictive claim. The sample size of forty is small, and the researchers themselves state that these exploratory biomarkers require confirmation in larger prospective cohorts. What the study does not do is displace the existing cornerstone of monitoring: routine urinalysis remains essential for every child with IgA vasculitis, since detecting blood or protein in the urine is still the most direct way to identify emerging nephritis.

Even with those caveats, the study contributes to a growing effort to complement urine testing with inexpensive blood-based markers available at the bedside on day one. The neutrophil-to-lymphocyte ratio, serum osmolarity, urea, and vitamin B12 all come from tests that virtually any hospital can perform within minutes, and a validated panel of such markers could, in principle, help clinicians stratify patients into closer follow-up schedules. Until replication studies confirm and extend these associations, the practical takeaway for clinicians is continuity rather than change: keep the six-month urinalysis vigil, and treat the new laboratory signals as hypotheses worth testing, not verdicts. The study received no external funding, was approved by the ethics committee of Fırat University Faculty of Medicine, and was published as open-access research, allowing clinicians and researchers worldwide to examine the data behind these early associations as the field works toward larger validation efforts.

Subject of Research: Biomarkers associated with renal involvement in childhood IgA vasculitis

Article Title: Clinical and laboratory parameters associated with renal involvement in childhood IgA vasculitis: a prospective cohort study

Article References: Clinical and laboratory parameters associated with renal involvement in childhood IgA vasculitis: a prospective cohort study. (n.d.). https://doi.org/10.1186/s12887-026-07809-z

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07809-z

Keywords: IgA vasculitis, Henoch-Schönlein purpura, pediatric nephrology, neutrophil-to-lymphocyte ratio, serum osmolarity, vitamin B12, renal involvement, IgA vasculitis nephritis, biomarkers, prospective cohort study, urinalysis, children's health